Lyso-Gb1 as a biomarker of treatment outcomes in Gaucher disease: An evaluation of data from the Gaucher Outcome Survey (GOS) registry

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []